| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 4.595 | 47.578 | 55.792 | 72.753 | 148.129 | 178.634 | 192.574 |
| Total Income - EUR | - | - | - | 11.010 | 56.423 | 62.385 | 78.089 | 150.834 | 188.717 | 194.114 |
| Total Expenses - EUR | - | - | - | 33.319 | 56.135 | 59.484 | 72.132 | 97.636 | 107.672 | 117.249 |
| Gross Profit/Loss - EUR | - | - | - | -22.309 | 289 | 2.901 | 5.957 | 53.198 | 81.046 | 76.865 |
| Net Profit/Loss - EUR | - | - | - | -22.355 | -185 | 2.470 | 5.326 | 51.724 | 79.211 | 71.203 |
| Employees | - | - | - | 3 | 5 | 5 | 4 | 7 | 7 | 6 |
Check the financial reports for the company - Quark Diagnostics & Treatment Center Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 30.598 | 20.943 | 13.657 | 8.365 | 5.405 | 3.849 | 2.297 |
| Current Assets | - | - | - | 4.410 | 5.939 | 3.155 | 6.059 | 43.635 | 82.927 | 79.076 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 1.772 | 4.465 | 2.814 | 659 | 28.384 | 68.037 | 53.540 |
| Cash | - | - | - | 2.638 | 1.474 | 340 | 5.399 | 15.251 | 14.891 | 25.537 |
| Shareholders Funds | - | - | - | -22.312 | -21.921 | -19.035 | -13.287 | 38.396 | 79.304 | 71.295 |
| Social Capital | - | - | - | 43 | 80 | 79 | 77 | 77 | 77 | 76 |
| Debts | - | - | - | 29.303 | 30.261 | 24.589 | 21.469 | 7.348 | 6.319 | 9.354 |
| Income in Advance | - | - | - | 28.745 | 19.344 | 12.386 | 7.122 | 4.447 | 2.894 | 1.346 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Quark Diagnostics & Treatment Center Srl